In fact, the mean number of stromal CD20+ B cells was significantly lower in T3 and T4 tumors compared with T1 and T2, as well as in those patients who did not develop a second primary oral carcinoma (Table 2). This evidence concerns the gene MS4A1 and lip and oral cavity carcinoma.